DOXORUBICIN for Hypercholesterolaemia: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 5 adverse event reports in the FDA FAERS database where DOXORUBICIN was used for Hypercholesterolaemia.
Most Reported Side Effects for DOXORUBICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 8,844 | 10.7% | 1,075 | 5,491 |
| Off label use | 7,858 | 9.5% | 1,712 | 2,385 |
| Disease progression | 6,165 | 7.5% | 1,384 | 865 |
| Neutropenia | 5,891 | 7.1% | 927 | 2,104 |
| Drug ineffective | 4,598 | 5.6% | 1,342 | 1,068 |
| Pyrexia | 3,697 | 4.5% | 482 | 2,503 |
| Thrombocytopenia | 3,638 | 4.4% | 645 | 1,330 |
| Anaemia | 3,601 | 4.4% | 555 | 1,566 |
| Product use in unapproved indication | 3,502 | 4.2% | 821 | 978 |
| Nausea | 2,925 | 3.5% | 279 | 1,405 |
| Sepsis | 2,740 | 3.3% | 1,481 | 1,198 |
| Pneumonia | 2,611 | 3.2% | 839 | 1,521 |
| Death | 2,515 | 3.0% | 2,514 | 299 |
| Diarrhoea | 2,330 | 2.8% | 403 | 1,216 |
| Vomiting | 2,279 | 2.8% | 310 | 1,233 |
Other Indications for DOXORUBICIN
Diffuse large b-cell lymphoma (15,213)
Product used for unknown indication (5,186)
Hodgkin's disease (4,606)
B-cell lymphoma (3,947)
Breast cancer (3,641)
Non-hodgkin's lymphoma (3,298)
Acute lymphocytic leukaemia (3,128)
Plasma cell myeloma (2,820)
Chemotherapy (1,756)
Ovarian cancer (1,692)
Other Drugs Used for Hypercholesterolaemia
EVOLOCUMAB (23,505)
ATORVASTATIN (5,615)
ALIROCUMAB (4,924)
SIMVASTATIN (3,010)
ROSUVASTATIN (2,690)
EZETIMIBE (1,589)
PRAVASTATIN (764)
INCLISIRAN (486)
FENOFIBRATE (286)
FLUVASTATIN (264)